Longitudinal BMI change and outcomes in Chronic Obstructive Pulmonary Disease: a nationwide population-based cohort study
Open Access
- 30 March 2024
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 25 (1) , 1-10
Abstract
Background: The association between longitudinal body mass index (BMI) change and clinical outcomes in patients with chronic obstructive pulmonary disease (COPD) has not fully investigated. Methods: This retrospective cohort study included 116,463 COPD patients aged ≥ 40, with at least two health examinations, one within 2 years before and another within 3 years after COPD diagnosis (January 1, 2014, to December 31, 2019). Associations between BMI percentage change with all-cause mortality, primary endpoint, and initial severe exacerbation were assessed. Results: BMI decreased > 5% in 14,728 (12.6%), while maintained in 80,689 (69.2%), and increased > 5% in 21,046 (18.1%) after COPD diagnosis. Compared to maintenance group, adjusted hazard ratio (aHR) for all-cause mortality was 1.70 in BMI decrease group (95% CI:1.61, 1.79) and 1.13 in BMI increase group (95% CI:1.07, 1.20). In subgroup analysis, decrease in BMI showed a stronger effect on mortality as baseline BMI was lower, while an increase in BMI was related to an increase in mortality only in obese COPD patients with aHRs of 1.18 (95% CI: 1.03, 1.36). The aHRs for the risk of severe exacerbation (BMI decrease group and increase group vs. maintenance group) were 1.30 (95% CI:1.24, 1.35) and 1.12 (95% CI:1.07, 1.16), respectively. Conclusions: A decrease in BMI was associated with an increased risk of all-cause mortality in a dose-dependent manner in patients with COPD. This was most significant in underweight patients. Regular monitoring for weight loss might be an important component for COPD management.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (2021R1A2C2093987)
This publication has 31 references indexed in Scilit:
- Probability of 5% or Greater Weight Loss or BMI Reduction to Healthy Weight Among Adults With Overweight or ObesityJAMA Network Open, 2023
- Association Between Regular Moderate to Vigorous Physical Activity Initiation Following COPD Diagnosis and MortalityChest, 2023
- Mortality risk attributable to classification of chronic obstructive pulmonary disease and reduced lung function: A 21-year longitudinal cohort studyRespiratory Medicine, 2021
- Low BMI and weight loss aggravate COPD mortality in men, findings from a large prospective cohort: the JACC studyScientific Reports, 2021
- Muscle-strengthening and aerobic activities and mortality among 3+ year cancer survivors in the U.S.Cancer Causes & Control, 2018
- Body weight and mortality in COPD: focus on the obesity paradoxEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2017
- Obesity Is Associated With Increased Morbidity in Moderate to Severe COPDChest, 2017
- The Obesity Paradox in Cancer: a ReviewCurrent Oncology Reports, 2016
- Is 5% weight loss a satisfactory criterion to define clinically significant weight loss?Obesity, 2015
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesThe Lancet, 2004